Öz
Sonuç:
Orta-ağır bronşiyolitli hastalarda miyokard işlev bozukluğu olmaksızın plazma BNP artışı görülebilir. Bu artış, hastalığa bağlı pulmoner gaz değişimindeki bozulmanın derecesi ile ilişkili olabilir. Plazma BNP düzeyi, orta-ağır bronşiyolitli hastalarda hastalık seyrini öngörmede potansiyel bir biyobelirteçtir.
Bulgular:
Hastaların ortalama plazma BNP düzeyi, sağlıklı kontrol grubundan yüksek saptandı (61,75±65 pg/mL’ye karşılık 13,99±8,79 pg/mL, p=0,001). Plazma BNP düzeyi normal ve yüksek olan hastalar ile sağlıklı kontrol grubunun ejeksiyon fraksiyonu ve fraksiyonel kısalma değerleri arasında fark saptanmadı (p>0,05). Plazma BNP düzeyi yüksek olan hastaların ortalama kısmi karbondioksit basıncı değeri, BNP düzeyi normal olan hastalardan yüksek bulundu (p=0,037). Plazma BNP düzeyi ile hastanede yatış süresi (r=0,286; p=0,007) ve yoğun bakımda yatış süresi (r=0,645; p=0,000) arasında pozitif bir korelasyon saptandı.
Yöntemler:
Çalışmada bronşiyolit tanısı alan, modifiye Wang solunum skoru ≥6 olan, 1-24 ay arasındaki 37 hasta ileriye dönük olarak incelendi. Plazma BNP düzeyi yüksek (>100 pg/mL, n=6) ve normal (≤100 pg/mL, n=31) olan hastalar sol ventrikül sistolik işlevleri, yaşamsal bulgular, laboratuvar sonuçları ve radyolojik bulgular açısından karşılaştırıldı. Plazma BNP düzeyi ile prognoz arasındaki ilişki değerlendirildi.
Giriş:
Bronşiyolitli hastalarda plazma B tipi natriüretik peptid (BNP) düzeyinin klinik önemi ve hastalık seyri ile ilişkisi konusunda bilgimiz sınırlıdır. Bu çalışmanın amacı orta-ağır bronşiyolit tanısı ile hastaneye yatırılan ve eşlik eden başka hastalığı olmayan hastaların bazal plazma BNP değerleri ile sol ventrikül sistolik fonksiyonları ve hastalık prognozu arasındaki ilişkiyi araştırmaktır.
Anahtar Kelimeler: Bronşiyolit, bebek, B-tipi natriüretik peptid, miyokard disfonksiyonu, prognoz
Kaynakça
Checchia PA, Appel HJ, Kahn S, Smith FA, Shulman ST, et al. Myocardial injury in children with respiratory syncytial virus infection. Pediatr Crit Care Med. 2000;1:146-50.
Huang M, Bigos D, and Levine M. Ventricular arrhythmia associated with respiratory syncytial viral infection. Pediatr Cardiol. 1998;19:498-500.
Armstrong D and Menahem S. Cardiac arrhythmias as a manifestation of acquired heart disease in association with paediatric respiratory syncitial virus infection. J Paediatr Child Health. 1993;29:309-11.
Menchise A. Myocarditis in the setting of RSV bronchiolitis. Fetal Pediatr Pathol 2011;30:64-8.
Eisenhut M, Sidaras D, Johnson R, Newland P, and Thorburn K. Cardiac troponin T levels and myocardial involvement in children with severe respiratory syncytial virus lung disease. Acta Paediatr. 2004;93:887-90.
Akcan AB and Oygur N. Brain natriuretic peptide and applications in pediatrics/Beyin natriuretik peptid ve pediatride kullanim alanlari. J Current Pediatrics. 2010;8:67-72.
Berger R, Huelsman M, Strecker K, Bojic A, Moser P, et al. B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure. Circulation. 2002;105:2392-97.
Davis GK, Bamforth F, Sarpal A, Dicke F, Rabi Y, et al. B-type natriuretic peptide in pediatrics. Clin Biochem. 2006;39:600-5.
Hammerer-Lercher A, Geiger R, Mair J, Url C, Tulzer G, et al. Utility of N-terminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients. Clin Chem. 2006;5:1415-19.
Kalra PR, Anker SD, and AJS Coats. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Cardiovasc Res. 2001;51:495-509.
Sahingozlu T, Karadas U, Eliacik K, Bakiler AR, Ozdemir Karadas N, et al. Brain natriuretic peptide: the reason of respiratory distress is heart disease or lung disease? Am J Emerg Med. 2015;33:697-700.
Daneshmand KA, Zaritsky AL, Lamb MA, LeVine AM, Sanders RC. Plasma concentration of N-terminal pro-atrial and N-terminal pro-brain natriuretic peptides and fluid balance in children with bronchiolitis. J Ped Intensive Care. 2012;3:143-51.
Coates BM, Camarda LE, and Goodman DM. Wheezing in Infants: Bronchiolitis. 2044-2048. In: Kliegman S, Stanton BF, St Geme JW, Schor NF (Eds). Nelson Textbook of Pediatrics (20th Ed). Philadelphia, PA: Elsevier, 2016.
Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis. 1992;145:106-9.
Bressan S, Balzani M, Krauss B, Pettenazzo A, Zanconato S, et al. High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study. Eur J Pediatr. 2013;172:1649-56.
Teichholz LE, Cohen MV, Sonnenblick EH, and Gorlin R. Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy. N Engl J Med. 1974;291:1220-26.
Cohen S, Springer C, Avital A, Perles Z, Rein AJ, et al. Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? Pediatrics. 2005;115:1347-50.
Evim MS, Uçar B, Kiliç Z, and Colak OF. The value of plazma N-terminal pro-brain natriuretic peptide levels in the differential diagnosis and follow-up of congestive cardiac failure and respiratory distress due to pulmonary aetiologies in infants and children. Cardiol Young. 2010;20:495-504.
Nevo I, Erlichman M, Algur N, and Nir A. N-terminal pro B-type natriuretic peptide levels in infants and children with acute non-cardiac diseases. Isr Med Assoc J. 2011;13:420-24.
Shor R, Rozenman Y, Bolshinsky A, Harpaz D, Tilis Y, et al. BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006;17:536-40.
Piechota M, Barylski M, Hannam S, Mikhailidis DP, Rysz J, et al. Natriuretic peptides in septic patients. Curr Med Chem. 2009;16:4020-31.
Klouche K, Pommet S, Amigues L, Bargnoux AS, Dupuy AM, et al. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality. J Intensive Care Med. 2014;29:229-37.
Tomaru KK, Arai M, Yokoyama T, Aihara Y, Sekiguchi KK, et al. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 2002;34:649-59.
Matsuda K, Tsutsumi H, Okamoto Y, and Chiba C. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Lab Immunol. 1995;2:322-24.
Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995;171:584-92.
Fried I, Bar-Oz B, Algur N, Fried E, Gavri S, et al. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics. 2006;118:1165-68.
Cowie MR and GF Mendez. BNP and congestive heart failure. Prog Cardiovasc Dis. 2002;44:293-321.
Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis. 2004;44:420-28.
Christ-Crain M, Breidthardt T, Stolz D, Zobrist K, Bingisser R, et al. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. J Intern Med. 2008;264:166-76.
Nowak A, Breidthardt T, Christ-Crain M, Bingisser R, Meune C, et al. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia. Chest. 2012;141:974-82.
Anıl M, Göç Z, Avcı R, Gökalp G, Bıcılıoğlu Y, et al. B-type natriuretic peptide is a useful biomarker predicting disease severity in children with isolated bronchiolitis in the emergency department. Turk J Pediatr. 2017;59:561-69.
